Whitepaper

There is no glory in oversight and governance. There is no virtual reality to immerse. There are no dazzling 3D images. There is nothing that makes people: “That is very interesting and cool!” Instead, governance is decidedly unattractive. It is tedious. It is painstaking diligence. It is an ethical review. It is checking, double checking and checking one more time for good measure. It is an exercise in patience that challenges even the most “detailed” people. It is a seemingly endless chore.
It is also the most important enterprise strategy in drug development. Given the enormous amount of work involved with oversight, governance and project management, it’s no wonder cross-functional teams bring this to the table for discussions. But its proponents — most notably that who have succeeded with it — insist that the end result is worth the tremendous effort. It is amazing how much data embedded within each department / function.

There are 100s of data points relevant to the concerns about each area even though there are about 1000s of data points out there.